Results 81 to 90 of about 87,239 (208)

Surgery versus chemoradiotherapy in patients with stage T1bN0M0 esophageal cancer: a retrospective cohort study

open access: yesScientific Reports
To compare survival outcomes between surgery and chemoradiotherapy in patients with stage T1bN0M0 esophageal cancer. Stage T1bN0M0 esophageal cancer patients treated with either surgery or chemoradiotherapy were extracted from the Surveillance ...
Zu-Yi Chen   +5 more
doaj   +1 more source

Surgical outcome following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. [PDF]

open access: yes, 2008
INTRODUCTION : The potential for curative resection is the most important component of the multimodality management of rectal cancer. In locally advanced rectal cancer lymph node involvement and positive resection margins are common, leading to local ...
Yamini Chitra, V
core  

Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer:A retrospective comparison of two Dutch tertiary referral centres [PDF]

open access: yes
Introduction: The effect of neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer, at increased risk of failing current treatment regimens, is unknown.
Rutten, H. J. T.   +17 more
core   +1 more source

Chemoradiotherapy versus radiotherapy in patients with stage T1-2N0M0 small cell lung cancer: a retrospective cohort study

open access: yesBMC Pulmonary Medicine
Purpose To compare survival outcomes between chemoradiotherapy versus radiotherapy in patients with stage T1-2N0M0 small cell lung cancer (SCLC). Materials and methods SCLC patients from the Surveillance, Epidemiology, and End Results databases between ...
Juan Lin   +4 more
doaj   +1 more source

The role of ADAM10 in the prediction of neoadjuvant chemoradiotherapy response in patients with locally advanced rectal cancer

open access: yes
Protease ADAM10, a member of the A disintegrin and metalloproteinase protein family, plays a role in cytokine/growth factor release, the shedding of receptor molecules from the membrane, and intracellular signaling.
Misirlić-Denčić, Sonja   +6 more
core   +1 more source

Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer

open access: yes
Höppner J, Brunner T, Schmoor C, et al. Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer. New England Journal of Medicine.
Gerdes, Berthold   +32 more
core   +1 more source

Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot

open access: yes, 2016
Shruti GuhaSarkar,1 Kamal Pathak,2 Niyati Sudhalkar,3 Prachi More,1 Jayant Sastri Goda,3 Vikram Gota,2 Rinti Banerjee1 1Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 2Department of Clinical Pharmacology ...
Gota V   +6 more
core  

Impact of Body Weight Loss During Preoperative Chemoradiotherapy on Prognosis of Patients With Lower Rectal Cancer

open access: yesAnnals of Gastroenterological Surgery
Background Preoperative chemoradiotherapy is the standard treatment for locally advanced rectal cancer (LARC), but may cause body composition changes. The prognostic impact of these changes remains unclear. The present study investigated the relationship
Shinya Abe   +9 more
doaj   +1 more source

A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma

open access: yes, 2018
Shuai Zhang, Liya Zhou, Xiaopeng Huang, Shaomin Lin Department of Radiation Oncology, Hainan General Hospital, Haikou 570311, Hainan, China Introduction: The purpose of this study was to analyze the efficacy and safety of concurrent chemoradiotherapy ...
Zhou L, Lin S, Huang X, Zhang S
core  

Microbiota in cancer chemoradiotherapy resistance [PDF]

open access: yesClinical and Translational Medicine, 2020
He, Yan   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy